Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for cutaneous use. It treats fungal skin infections such as athlete's foot, ringworm, jock itch, and related conditions in patients of all ages.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil is an allylamine antifungal used to treat superficial fungal infections of the skin.

- Tinea pedis: reduces itching and clears infection of the feet. - Tinea corporis: eliminates ring‑shaped lesions on the body. - Tinea cruris: relieves jock itch symptoms and eradicates the fungus. - Tinea versicolor: restores normal skin coloration by clearing yeast overgrowth. - Superficial dermatophytosis: treats various skin‑surface fungal infections.

Topical terbinafine may cause local skin reactions.

Common Side Effects: - Itching or pruritus at the application site. - Burning or stinging sensation. - Redness or erythema. - Dryness or scaling of the skin. - Mild irritation or rash.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Contact dermatitis with blistering. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic absorption leading to liver enzyme abnormalities (rare).

Before using Lamisil, consider the following safety measures.

- Assess hypersensitivity: avoid if known allergy to terbinafine or similar agents. - Avoid broken skin: do not apply to open wounds or inflamed areas. - Eye protection: keep product away from eyes and mucous membranes. - Duration limit: use only for the prescribed treatment period. - Extensive use monitoring: watch for signs of systemic absorption in large‑area applications. - Store at room temperature: keep in original container, protect from moisture and light.

Terbinafine topical has limited systemic interactions, but caution is advised with certain co‑administered products.

Major Interactions (Avoid): - Concurrent use of other topical antifungals containing the same active ingredient. - Application with potent topical corticosteroids that may mask irritation.

Moderate Interactions (Monitor Closely): - Simultaneous oral terbinafine therapy may increase systemic exposure. - Use with other skin irritants (e.g., chemical peels) may exacerbate local reactions. - Combination with photosensitizing agents may increase sun sensitivity.